{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory+Tissue+Disorder&page=4", "query": { "condition": "Inflammatory Tissue Disorder", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 482, "total_pages": 49, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory+Tissue+Disorder&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory+Tissue+Disorder&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T09:14:52.969Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03497897", "title": "Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Inflammatory Acne" ], "interventions": [ { "name": "LYS006 20 mg", "type": "DRUG" }, { "name": "LYS006 2 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 66, "start_date": "2018-09-10", "completion_date": "2022-03-09", "has_results": true, "last_update_posted_date": "2023-08-31", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 7, "location_summary": "Fremont, California • Santa Monica, California • Hialeah, Florida + 4 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03497897" }, { "nct_id": "NCT00126724", "title": "Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid", "Arthritis, Psoriatic", "Ankylosing Spondylitis" ], "interventions": [ { "name": "tgAAC94 gene therapy vector", "type": "GENETIC" }, { "name": "tgAAC94 placebo", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Targeted Genetics Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 120, "start_date": "2005-08", "completion_date": "2009-05", "has_results": false, "last_update_posted_date": "2009-07-29", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 22, "location_summary": "Glendale, Arizona • Tuscon, Arizona • Palm Desert, California + 18 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Tuscon", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00126724" }, { "nct_id": "NCT03242473", "title": "Comparing the Effects of Lactated Ringers and Normal Saline in Acute Pancreatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pancreatitis" ], "interventions": [ { "name": "Fluid Management", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "0 Years to 18 Years" }, "enrollment_count": 79, "start_date": "2014-12", "completion_date": "2020-10-23", "has_results": false, "last_update_posted_date": "2021-08-17", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 3, "location_summary": "Washington D.C., District of Columbia • Cincinnati, Ohio • Norfolk, Virginia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03242473" }, { "nct_id": "NCT01307423", "title": "Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast 20mg", "type": "DRUG" }, { "name": "Apremilast 30mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 529, "start_date": "2010-12-09", "completion_date": "2017-08-16", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Palm Desert, California • Doral, Florida + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01307423" }, { "nct_id": "NCT06587828", "title": "A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Autoimmune Diseases", "Ulcerative Colitis", "Multiple Sclerosis", "Scleroderma", "Ankylosing Spondylitis", "Celiac Disease", "Non-radiographic Axial Spondyloarthritis (Nr-axSpA)", "Crohn&Amp;#39;s Disease", "Birdshot Chorioretinitis" ], "interventions": [ { "name": "Companion blood samples with procedure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "TScan Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 238, "start_date": "2023-01-03", "completion_date": "2026-09-10", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 11, "location_summary": "Orange, California • Sherman Oaks, California • Skokie, Illinois + 7 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Sherman Oaks", "state": "California" }, { "city": "Skokie", "state": "Illinois" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06587828" }, { "nct_id": "NCT00513695", "title": "Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Inflammatory Breast Cancer", "Male Breast Cancer", "Stage II Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer" ], "interventions": [ { "name": "sunitinib malate", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "therapeutic conventional surgery", "type": "PROCEDURE" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "flow cytometry", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "PROCEDURE", "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 68, "start_date": "2007-06", "completion_date": "2017-10-16", "has_results": true, "last_update_posted_date": "2019-08-07", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 7, "location_summary": "Anchorage, Alaska • Tucson, Arizona • Boise, Idaho + 3 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Boise", "state": "Idaho" }, { "city": "Mount Vernon", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00513695" }, { "nct_id": "NCT01364389", "title": "A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Polymyalgia Rheumatica", "Inflammatory Diseases" ], "interventions": [ { "name": "AIN457", "type": "DRUG" }, { "name": "ACZ885", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 16, "start_date": "2011-02-14", "completion_date": "2013-01-29", "has_results": true, "last_update_posted_date": "2021-09-17", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01364389" }, { "nct_id": "NCT02971748", "title": "Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anatomic Stage IIIB Breast Cancer AJCC v8", "Anatomic Stage IIIC Breast Cancer AJCC v8", "Breast Inflammatory Carcinoma", "Prognostic Stage IIIB Breast Cancer AJCC v8", "Prognostic Stage IIIC Breast Cancer AJCC v8" ], "interventions": [ { "name": "Pembrolizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2017-01-26", "completion_date": "2027-12-31", "has_results": true, "last_update_posted_date": "2026-06-11", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02971748" }, { "nct_id": "NCT00001261", "title": "Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dermatomyositis", "Inclusion Body Myositis", "Polymyositis" ], "interventions": [ { "name": "Gamma Globulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 120, "start_date": "1990-05", "completion_date": "2002-07", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001261" }, { "nct_id": "NCT02798211", "title": "Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Secukinumab 300 mg", "type": "DRUG" }, { "name": "Secukinumab 150 mg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 258, "start_date": "2016-06-27", "completion_date": "2018-12-05", "has_results": true, "last_update_posted_date": "2021-10-07", "last_synced_at": "2026-10-22T09:14:52.969Z", "location_count": 57, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • El Cajon, California + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "El Cajon", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02798211" } ] }